Eradication of hepatitis C virus after a 5-week treatment

被引:0
|
作者
Mbethe, G. L. Gaundong [1 ]
Foucher, J. [1 ]
DeLedinghen, V. [1 ]
Couzigou, V. P. [1 ]
机构
[1] CHU Bordeaux, Hop Haute Leveque, Serv Hepatogastroenterol, F-33604 Pessac, France
来源
REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 10期
关键词
Chronic hepatitis C; Genotype; 2; Short-term therapy; PEGINTERFERON ALPHA-2B; COMBINATION THERAPY; HCV GENOTYPE-2; RIBAVIRIN; INTERFERON;
D O I
10.1016/j.revmed.2009.03.358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The standard regimen for the treatment of chronic hepatitis C virus (HCV) is peginterferon alpha-2a or -2b associated with ribavirine. The recommended duration of treatment for genotype 2 HCV infection is 24 weeks. However, the relatively poor drug tolerance often leads to a reduction or a discontinuation of the treatment. Here, we report two female patients who discontinued antiviral therapy after less than 6 weeks for intolerance and who experienced a sustained virological response. A treatment of 3 to 5 weeks may be enough for genotype 2 HCV eradication. However, there is not sufficient evidence in 2009 to recommend a reduced treatment duration. (C) 2009 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:900 / 903
页数:4
相关论文
共 50 条
  • [21] The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia HCC after HCV eradication in hemophilia
    Inukai, Yosuke
    Imai, Norihiro
    Yamamoto, Kenta
    Ito, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Okamoto, Shuichi
    Kanematsu, Takeshi
    Suzuki, Nobuaki
    Matsushita, Tadashi
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    ANNALS OF HEPATOLOGY, 2022, 27 (01)
  • [22] The Challenging Road to Hepatitis C Virus Eradication
    Martinez, Isidoro
    Ryan, Pablo
    Valencia, Jorge
    Resino, Salvador
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04)
  • [23] Nanodiagnostics in global eradication of hepatitis C virus
    Darvishi, Mohammad
    Amiri, Reza
    Ghannad, Emad
    Mehrabkhani, Samir
    Rastgar, Nassim
    Razaghi, Mahkameh
    Bansal, Jaya
    Chahar, Mamata
    Rajput, Pranchal
    Saffarfar, Hossein
    Ali-Khiavi, Payam
    Mobed, Ahmad
    Yazdani, Yalda
    CLINICA CHIMICA ACTA, 2025, 565
  • [24] RISK OF HEPATOCARCINOGENESIS AFTER ERADICATION OF HEPATITIS C VIRUS BY DIRECT ACTING ANTIVIRALS
    Kawaguchi, Yasunori
    Otsuka, Taiga
    Yoshioka, Wataru
    Noge, Shotaro
    Takahashi, Hirokazu
    Eguchi, Yuichiro
    Ozaki, Iwata
    Okada, Michiaki
    Yanagita, Kimihiko
    Kohira, Toshikazu
    Ide, Yasushi
    Yasutake, Tsutomu
    Kawasoe, Hiroaki
    Mizuta, Toshihiko
    GASTROENTEROLOGY, 2017, 152 (05) : S1099 - S1099
  • [25] New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradication
    Pan, Calvin Q.
    Park, Andrew J.
    Park, James S.
    GASTROENTEROLOGY REPORT, 2024, 12
  • [26] Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus
    Takeda, Haruhiko
    Takai, Atsushi
    Iguchi, Eriko
    Mishima, Masako
    Arasawa, Soichi
    Kumagai, Ken
    Eso, Yuji
    Shimizu, Takahiro
    Takahashi, Ken
    Ueda, Yoshihide
    Taura, Kojiro
    Hatano, Etsuro
    Iijima, Hiroko
    Aoyagi, Haruyo
    Aizaki, Hideki
    Marusawa, Hiroyuki
    Wakita, Takaji
    Seno, Hiroshi
    CARCINOGENESIS, 2021, 42 (05) : 672 - 684
  • [27] Genetic features of hepatocellular carcinoma arising after eradication of hepatitis C virus
    Takeda, Haruhiko
    Takai, Atsushi
    Kim, Soo Ki
    Kakiuchi, Nobuyuki
    Seno, Hiroshi
    Ogawa, Seishi
    Marusawa, Hiroyuki
    CANCER SCIENCE, 2018, 109 : 1119 - 1119
  • [28] Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
    Rockey, Don C.
    Friedman, Scott L.
    GASTROENTEROLOGY, 2021, 160 (05) : 1502 - +
  • [29] What occurs after hepatitis C virus eradication? The key role of the internist
    Durazzo, Marilena
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2020, 179 (11) : 610 - 611
  • [30] ANALYSIS OF IMMUNE MICROENVIRONMENT OF HEPATOCELLULAR CARCINOMA AFTER HEPATITIS C VIRUS ERADICATION
    Hiramatsu, Katsushi
    Nosaka, Takuto
    Saito, Yasushi
    Takahashi, Kazuto
    Naito, Tatsushi
    Ofuji, Kazuya
    Matsuda, Hidetaka
    Ohtani, Masahiro
    Nakamoto, Yasunari
    HEPATOLOGY, 2020, 72 : 658A - 659A